Stockscreener 앱 받기
1.23
2.38%
-0.03
시간 외 거래:
1.25
0.02
+1.63%
Humacyte Inc 주식(HUMA)의 최신 뉴스
Humacyte’s (HUMA) Statements to Investors Called Into Question in Light of FDA ViolationsHagens Berman - ACCESS Newswire
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of January 17, 2025 in Humacyte, Inc. LawsuitHUMA - ACCESS Newswire
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Humacyte, Inc. (HUMA) Shareholders - ACCESS Newswire
Levi & Korsinsky Notifies Shareholders of Humacyte, Inc.(HUMA) of a Class Action Lawsuit and an Upcoming Deadline - ACCESS Newswire
Press Release Distribution & PR Platform - ACCESS Newswire
Shareholders that lost money on Humacyte, Inc.(HUMA) should contact Levi & Korsinsky about pending Class ActionHUMA - ACCESS Newswire
Humacyte, Inc. (HUMA) Beats Stock Market Upswing: What Investors Need to Know - MSN
Humacyte Insiders Placed Bullish Bets Worth US$949.4k - Yahoo Finance
All You Need to Know About Humacyte, Inc. (HUMA) Rating Upgrade to Buy - Yahoo Finance
Humacyte, Inc. (HUMA) Stock Moves -0.68%: What You Should Know - MSN
Humacyte, Inc. (HUMA) Stock Sinks As Market Gains: Here's Why - MSN
Shareholders that lost money on Humacyte, Inc. (HUMA) should contact Levi & Korsinsky about pending Class ActionHUMA - ACCESS Newswire
Shareholders that lost money on Humacyte, Inc.(HUMA) Urged to Join Class ActionContact Levi & Korsinsky to Learn More - ACCESS Newswire
Humacyte, Inc. (NASDAQ:HUMA): Is Breakeven Near? - simplywall.st
5.24%
자본화:
|
볼륨(24시간):